Case number 1:23-cv-00551
Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 19, 2023 | 1 | Complaint* (1) |
| May 19, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 05/19/2023) (3) |
| May 19, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: April 5, 2023. Date of Expiration of Patent: U.S. Patent 10,828,310 expires on January 31, 2039, and U.S. Patent 7,157,456 expires on August 28, 2024. (mkr) (Entered: 05/19/2023) (1) |
| May 19, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (mkr) (Entered: 05/19/2023) (1) |
| May 19, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer Pharma AG. (mkr) (Entered: 05/19/2023) (1) |
| May 19, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc. (mkr) (Entered: 05/19/2023) (1) |
| May 19, 2023 | 7 | Summons Issued as to Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. (Attachments: # 1 Summons Issued)(mkr) (Entered: 05/19/2023) (Main Document) (2) |
| May 19, 2023 | 7 | Summons Issued as to Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. (Attachments: # 1 Summons Issued)(mkr) (Entered: 05/19/2023) (Summons Issued) (2) |
